News Home

Is Myovant Sciences Ltd (MYOV) a Good Buy in the Healthcare Sector?

Wednesday, October 05, 2022 01:10 PM | InvestorsObserver Analysts

Mentioned in this article

Is Myovant Sciences Ltd (MYOV) a Good Buy in the Healthcare Sector?

Myovant Sciences Ltd (MYOV) is near the top in its sector according to InvestorsObserver. MYOV gets an overall rating of 94. That means it scores higher than 94% of stocks. Myovant Sciences Ltd gets a 76 rank in the Healthcare sector. Healthcare is number 2 out of 11 sectors.

Overall Score - 94
MYOV has an Overall Score of 94. Find out what this means to you and get the rest of the rankings on MYOV!

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 94 means the stock is more attractive than 94 percent of stocks. Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Myovant Sciences Ltd Stock Today?

Myovant Sciences Ltd (MYOV) stock is trading at $25.09 as of 1:10 PM on Wednesday, Oct 5, a decline of -$0.38, or -1.49% from the previous closing price of $25.47. The stock has traded between $24.75 and $25.57 so far today. Volume today is less active than usual. So far 685,037 shares have traded compared to average volume of 1,088,978 shares. Click Here to get the full Stock Report for Myovant Sciences Ltd stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App